ReceptivaDx is so far offered in 100 doctors’ offices across the U.S.
WRAL profiled Dr. Steven L. Young, reproductive endocrinologist and professor of obstetrics and gynecology at UNC OB-GYN, about his work on ReceptivaDx, the first diagnostic test for endometriosis. Dr. Young collaborated on this test with Dr. Bruce Lessey of the USC School of Medicine in Greenville, S.C.
For many women with unexplained infertility, ReceptivaDx offers answers. With the diagnosis comes an endometriosis treatment plan that could save years of emotional pain and tens of thousands of dollars. Until a few months ago, the only way to diagnose endometriosis in patients with no pain symptoms was through laparoscopic surgery.
“It’s hard for us to understand the disease when we don’t know who’s got it and who doesn’t unless we do surgery,” said Dr. Young.
For the test, an endometrial biopsy is performed and the biopsy is studied under a microscope. They’re looking for BCL6, a protein that appears in high levels in the uterine tissue of women with endometriosis. This could present more targeted treatment options for women with endometriosis.
Dr. Young sees patients and practices at UNC Fertility. To make an appointment, call 919-908-0000.